Related Experiment Video
Updated: Apr 30, 2026
Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
Monoclonal stool antigen test for diagnosing Helicobacter pylori in chronic atrophic gastritis: a prospective primary
Cheng Fang1, Peiwei Li1, Dingjiacheng Jia1
1Department of Gastroenterology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Background/Aims:
Diagnosing active Helicobacter pylori (H. pylori) infection in patients with chronic atrophic gastritis (CAG) remains challenging. The monoclonal stool antigen test (SAT) offers a non-invasive alternative to endoscopic methods. This study aimed to evaluate the diagnostic accuracy of SAT in CAG and to analyze its performance in relation to the severity of gastric atrophy.
Methods:
In this prospective study, 287 patients with CAG underwent SAT, urea breath test, serology, and histology. Patients were stratified into low-risk and high-risk groups based on gastric cancer progression risk. SAT was assessed against a reference standard combining histology and UBT.
Results:
The area under the ROC curve for SAT was 0.858. SAT showed a sensitivity of 75.9% and a specificity of 96.1%. In high-risk patients, SAT demonstrated comparable specificity (96.77% vs. 95.77%) and positive predictive value (95.24% vs. 93.48%) to those in low-risk patients, with numerically higher accuracy (89.29% vs. 86.05%). Consistency analysis revealed substantial agreement between SAT and the reference standard overall (κ=0.72), with stronger agreement in the high-risk patients (κ=0.77) than in the low-risk patients (κ=0.69).
Conclusions:
Monoclonal SAT is a reliable non-invasive tool for detecting H. pylori in CAG, exhibiting high specificity and strong diagnostic consistency. Its performance is positively correlated with the severity of gastric atrophy, supporting its preferential use in high-risk, advanced atrophy populations.
Related Concept Videos
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:30Serum Laboratory Studies, Stool Test, Breath Test
01:26Gastritis II: Pathophysiology
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...